Digital Pathology Market Is Anticipated To Boost The Segment Growth
Digital Pathology Industry Overview
The global digital pathology market size is expected to reach USD 1.74 billion by 2030, registering a CAGR of 7.5% over the forecast period, according to a new report by Grand View Research, Inc. Increasing prevalence of chronic diseases triggers the demand for advanced diagnostics, which is expected to drive the market growth. Growing economic stability and awareness about the benefits of the use of computer-aided diagnostics is further contributing to the market growth. As with other laboratory medicine disciplines, the COVID-19 pandemic has had a surprising impact on digital pathology. The pandemic has shortened all but the most serious surgeries and cancer treatments.
Thus, histology laboratories are involved in the most difficult task of collecting & analyzing tissue samples for the procedure. There was also a workforce shortage with many pathologists staying out of the laboratory due to physical distancing measures. Thus, altered rules allowed greater usage of digital pathology along with the reading of the test results from remote settings, which supported the overall market growth. During the pandemic, pathologists had to continue working from home. This formed an unprecedented necessity for home workplaces and protect clinical informatics solutions permitting clinicians to read images remotely and allowing real-time virtual alliance between their multi-disciplinary care teams.
Pre-COVID-19, pathology laboratories that digitized their workflows across diverse sites reported an average productivity gain of 21%. The COVID-19 pandemic augmented the implementation of digital pathology for several reasons, such as changes in regulatory requirements and governance. Technological advancements, such as digital imaging, computerization, robotic light microscopy, and multiple fiber optic communications are some of the key factors driving the adoption of digital pathology. In addition, the introduction of cloud-based technology enabling the storage of digital slides coupled with secure access to pathologists is expected to serve as a potential growth driver for the market.
Digital Pathology Market Segmentation
Grand View Research has segmented the global digital pathology market on the basis of the product, application, end-use, and region:
Based on the Product Insights, the market is segmented into Software, Device, and Storage System.
- The device segment dominated the market in 2021 and accounted for the largest revenue share of more than 52.0% 2021. The device segment includes scanner and slide management systems. Increasing adoption of academic research activities and enhanced resolution are the key growth drivers of the segment.
- This technology is expected to witness lucrative growth over the forecast period owing to advancements in magnification and scanning of slides at the Z-axis, which is offered by whole slide imaging. Moreover, intuitive user interfaces and high bandwidth connectivity are expected to boost its usage rates.
- OptraSCAN introduced OS-Ultra 320 high-speed scanners. The device is intended to scan cells/tissues of size 15x15 mm area at 40x magnification within 60 seconds. In addition, the high usage of scanners in pathology labs is further fueling market growth. Increasing R&D pertaining to applications, such as slide managers, is expected to boost the adoption of this technology in near future. The rising demand for an online storage system is further fueling market growth.
Based on the Application Insights, the market is segmented into Drug Discovery & Development, Academic Research, and Disease Diagnosis.
- The academic research application segment accounted for the largest share of more than 45.5% of the global revenue in 2021 and is projected to expand further at a steady CAGR from 2022 to 2030. The high share was attributed to the increased adoption of digital pathology in various research studies, such as tumor morphological research.
- The diagnosis segment is expected to witness the fastest CAGR over the forecast period. This growth can be credited to the rising prevalence of chronic diseases. Key manufacturers are focusing on the development of novel and rapid diagnostic techniques.
- Digital technologies help in improving each step in diagnostics. The cancer cell detection sub-segment is also expected to showcase lucrative growth in disease diagnosis over the forecast period. This is mainly due to the high prevalence of the disease coupled with various ongoing research initiatives.
Based on the End-use Insights, the market is segmented into Hospitals, Diagnostic Labs, Biotech & Pharma Companies, and Academic & Research Institutes.
- The hospital's segment accounted for the largest revenue share of more than 36% in 2021 owing to the high adoption of digital scanning techniques in hospitals for faster diagnosis and better patient compliance. In August 2020, Mackenzie Health partnered with Philips to become one of Canada’s first hospitals to introduce a modern digital pathology platform designed to assist patient diagnosis for faster & improved treatment.
- The diagnostic lab's segment is estimated to register the fastest CAGR from 2022 to 2030. The biotechnology & pharmaceutical companies segment is expected to have a steady growth over the forecast period. The growth is attributed to a rise in the usage of digital pathology in drug development, oncology clinical trials, and preclinical GLP pathology. A rise in the prevalence of cancer and high demand for better treatment options are further fueling the growth of this segment.
Intelligent Vending Machines Regional Outlook
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa (MEA)
Key Companies Profile & Market Share Insights
Major players, such as Danaher and Hamamatsu Photonics, Inc., held a dominant market share in 2021. These companies are increasingly undertaking various strategies, such as new product development, extensive collaborative strategies, and M&A, to gain a higher market share. For example, in April 2021, Leica Biosystems partnered with Paige to integrate its digital pathology platform with the latter’s AI-enabled research oncology software. This would extend access to computational pathology products for translational and clinical in select countries across the North America and Europe regions. In April 2021, Philips partnered with Ibex Medical Analytics to combine its digital pathology solutions with the latter’s AI-powered Galen platform, thus enhancing its offerings. While Oxford University Hospitals Cellular Pathology department completed 100% digitization of histology slides with the help of Philips. Some of the prominent players in the global digital pathology market include:
- Leica Biosystems (Danaher)
- Hamamatsu Photonics, Inc.
- Koninklijke Philips N.V.
- Olympus Corporation
- Hoffmann-La Roche Ltd.
- Mikroscan Technologies
- Inspirata, Inc.
- 3DHISTECH Ltd.
- Visiopharm A/S
- Huron Technologies International, Inc.
- ContextVision AB
Order a free sample PDF of the Digital Pathology Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Comments
Post a Comment